{"filing":{"accession_number":"0001829126-26-009351","cik":"0002059165","ticker":"SSEAR","company_name":"STARRY SEA ACQUISITION CORP","form":"8-K","filing_date":"2026-08-26","report_date":"2026-08-22","primary_document":"starrysea_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2059165/000182912626009351/starrysea_8k.htm"},"events":[{"id":29695,"run_id":27206,"accession_number":"0001829126-26-009351","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"This disclosure documents entry into a definitive merger agreement on August 22, 2026, whereby Starry Sea Acquisition Corp (SSEA), a SPAC, will merge with SuperiorMed Holdings Limited in a business combination. The agreement specifies the acquisition consideration ($200 million net value for SuperiorMed, payable in newly issued Purchaser Ordinary Shares at $10.00 per share), the merger structure (SPAC Merger followed by Acquisition Merger), board composition, and extensive closing conditions. This is a material acquisition transaction requiring shareholder approval and SEC registration statement approval, directly fitting Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.","company_name":"STARRY SEA ACQUISITION CORP","ticker":"SSEAR","filing_date":"2026-08-26","form":"8-K","submitted_at":null,"items":[{"id":32072,"accession_number":"0001829126-26-009351","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"This disclosure documents entry into a definitive merger agreement on August 22, 2026, whereby Starry Sea Acquisition Corp (SSEA), a SPAC, will merge with SuperiorMed Holdings Limited in a business combination. The agreement specifies the acquisition consideration ($200 million net value for SuperiorMed, payable in newly issued Purchaser Ordinary Shares at $10.00 per share), the merger structure (SPAC Merger followed by Acquisition Merger), board composition, and extensive closing conditions. This is a material acquisition transaction requiring shareholder approval and SEC registration statement approval, directly fitting Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T17:56:48.837599+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32072,"accession_number":"0001829126-26-009351","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"This disclosure documents entry into a definitive merger agreement on August 22, 2026, whereby Starry Sea Acquisition Corp (SSEA), a SPAC, will merge with SuperiorMed Holdings Limited in a business combination. The agreement specifies the acquisition consideration ($200 million net value for SuperiorMed, payable in newly issued Purchaser Ordinary Shares at $10.00 per share), the merger structure (SPAC Merger followed by Acquisition Merger), board composition, and extensive closing conditions. This is a material acquisition transaction requiring shareholder approval and SEC registration statement approval, directly fitting Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T17:56:48.837599+00:00","company_name":"STARRY SEA ACQUISITION CORP","ticker":"SSEAR","filing_date":"2026-08-26"}]}